Advertisement
CLNE vs GILD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNE is a StrongBuy and GILD is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLNE’s FA Score shows that 1 FA rating(s) are green whileGILD’s FA Score has 4 green FA rating(s).
- CLNE’s FA Score: 1 green, 4 red.
- GILD’s FA Score: 4 green, 1 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLNE’s TA Score shows that 4 TA indicator(s) are bullish while GILD’s TA Score has 4 bullish TA indicator(s).
- CLNE’s TA Score: 4 bullish, 4 bearish.
- GILD’s TA Score: 4 bullish, 2 bearish.
Price Growth
CLNE (@Oil Refining/Marketing) experienced а +8.33% price change this week, while GILD (@Pharmaceuticals: Major) price change was +3.38% for the same time period.
The average weekly price growth across all stocks in the @Oil Refining/Marketing industry was +0.90%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +6.18%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.31%. For the same industry, the average monthly price growth was +5.85%, and the average quarterly price growth was +12.45%.
Reported Earning Dates
CLNE is expected to report earnings on Nov 06, 2025.
GILD is expected to report earnings on Oct 23, 2025.
Industries' Descriptions
@Oil Refining/Marketing (+0.90% weekly)The Oil Refining/Marketing segment includes companies that refine crude oil into a number of petroleum products, including gasoline, jet fuel and diesel, and then sell the usable products to the end users. These companies are involved in what’s called downstream operations in the oil business. They also engage in the marketing and distribution of crude oil and natural gas products. In other words, the downstream oil and gas business is focused on post-production processes of crude oil and natural gas. When oil prices slump, downstream businesses are hurt less or in some cases even benefit, since their purchase cost of crude oil goes down. Some of the biggest U.S. oil refining/marketing companies include Phillips 66, Marathon Petroleum Corporation and Valero Energy Corp.
@Pharmaceuticals: Major (+3.31% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| CLNE | GILD | CLNE / GILD | |
| Capitalization | 583M | 90.8B | 1% |
| EBITDA | -31.92M | 10.5B | -0% |
| Gain YTD | -11.952 | 24.682 | -48% |
| P/E Ratio | N/A | 16.20 | - |
| Revenue | 425M | 27.1B | 2% |
| Total Cash | 263M | 7.26B | 4% |
| Total Debt | 361M | 25B | 1% |
CLNE | GILD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 15 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 98 | 15 | |
SMR RATING 1..100 | 96 | 29 | |
PRICE GROWTH RATING 1..100 | 49 | 21 | |
P/E GROWTH RATING 1..100 | 3 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GILD's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for CLNE (81) in the Gas Distributors industry. This means that GILD’s stock grew somewhat faster than CLNE’s over the last 12 months.
GILD's Profit vs Risk Rating (15) in the Biotechnology industry is significantly better than the same rating for CLNE (98) in the Gas Distributors industry. This means that GILD’s stock grew significantly faster than CLNE’s over the last 12 months.
GILD's SMR Rating (29) in the Biotechnology industry is significantly better than the same rating for CLNE (96) in the Gas Distributors industry. This means that GILD’s stock grew significantly faster than CLNE’s over the last 12 months.
GILD's Price Growth Rating (21) in the Biotechnology industry is in the same range as CLNE (49) in the Gas Distributors industry. This means that GILD’s stock grew similarly to CLNE’s over the last 12 months.
CLNE's P/E Growth Rating (3) in the Gas Distributors industry is significantly better than the same rating for GILD (100) in the Biotechnology industry. This means that CLNE’s stock grew significantly faster than GILD’s over the last 12 months.
| CLNE | GILD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | N/A |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 57% |
| Momentum ODDS (%) | 2 days ago 84% | 2 days ago 52% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 36% |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 77% | 2 days ago 60% |
| Advances ODDS (%) | 2 days ago 73% | 2 days ago 58% |
| Declines ODDS (%) | 9 days ago 85% | 7 days ago 50% |
| BollingerBands ODDS (%) | 2 days ago 89% | N/A |
| Aroon ODDS (%) | 2 days ago 67% | 3 days ago 43% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RIOX | 23.18 | 0.25 | +1.09% |
| Defiance Daily Target 2X Long RIOT ETF | |||
| ECF | 10.61 | 0.10 | +0.95% |
| Ellsworth Growth and Income Fund Ltd | |||
| NANR | 59.11 | 0.53 | +0.90% |
| SPDR S&P® North American Natural Res ETF | |||
| IDX | 15.31 | 0.04 | +0.29% |
| VanEck Indonesia ETF | |||
| SPLV | 73.48 | -0.17 | -0.23% |
| Invesco S&P 500® Low Volatility ETF | |||
CLNE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CLNE has been loosely correlated with PSX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CLNE jumps, then PSX could also see price increases.
| Ticker / NAME | Correlation To CLNE | 1D Price Change % | ||
|---|---|---|---|---|
| CLNE | 100% | +5.74% | ||
| PSX - CLNE | 41% Loosely correlated | +1.34% | ||
| DINO - CLNE | 39% Loosely correlated | +2.01% | ||
| PBF - CLNE | 38% Loosely correlated | +1.29% | ||
| PARR - CLNE | 35% Loosely correlated | +1.12% | ||
| AMTX - CLNE | 31% Poorly correlated | +5.10% | ||
More | ||||